Dixon, B. S., Beck, G. J., Dember, L. M., Depner, T. A., Gassman, J. J., Greene, T., … Feldman, H. I. (2006). Erratum: Design of the Dialysis Access Consortium (DAC) aggrenox prevention of access stenosis trial (Clinical Trials 2 (400-412)). Clinical Trials, 3(2), 160. https://doi.org/10.1191/1740774506cn146xx

Dixon, B. S., G. J. Beck, L. M. Dember, T. A. Depner, J. J. Gassman, T. Greene, J. Himmelfarb, et al. “Erratum: Design of the Dialysis Access Consortium (DAC) aggrenox prevention of access stenosis trial (Clinical Trials 2 (400-412)).” Clinical Trials 3, no. 2 (June 9, 2006): 160. https://doi.org/10.1191/1740774506cn146xx.

Dixon BS, Beck GJ, Dember LM, Depner TA, Gassman JJ, Greene T, et al. Erratum: Design of the Dialysis Access Consortium (DAC) aggrenox prevention of access stenosis trial (Clinical Trials 2 (400-412)). Clinical Trials. 2006 Jun 9;3(2):160.

Dixon, B. S., et al. “Erratum: Design of the Dialysis Access Consortium (DAC) aggrenox prevention of access stenosis trial (Clinical Trials 2 (400-412)).” Clinical Trials, vol. 3, no. 2, June 2006, p. 160. Scopus, doi:10.1191/1740774506cn146xx.

Dixon BS, Beck GJ, Dember LM, Depner TA, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kaufman JS, Lawson JH, Meyers CM, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI. Erratum: Design of the Dialysis Access Consortium (DAC) aggrenox prevention of access stenosis trial (Clinical Trials 2 (400-412)). Clinical Trials. 2006 Jun 9;3(2):160.